Iterum Therapeutics plc — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/37135370-cbd2-4fcc-89de-1d026f86d07a/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-24.8M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-015857 |
| FY 2023 | $-38.4M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-037615 |
| FY 2022 | $44.4M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-021500 |
| FY 2021 | $-91.6M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-011897 |
| FY 2020 | $-91.6M | 2020-01-01 – 2020-12-31 | evidence 0000950170-22-009792 |
| FY 2019 | $-103.1M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-010242 |
| FY 2018 | $-77.1M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-009089 |
| FY 2017 | $-29.4M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-021575 |
| FY 2016 | $-13.5M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-009089 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Iterum Therapeutics plc — all facts · Revenue · Operating Income